메뉴 건너뛰기




Volumn 210, Issue 3, 2013, Pages 605-621

Cytotoxic T cells induce proliferation of chronic myeloid leukemia stem cells by secreting interferon-γ

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN;

EID: 84877600876     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20121229     Document Type: Article
Times cited : (72)

References (73)
  • 1
    • 33747154547 scopus 로고    scopus 로고
    • Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
    • European LeukemiaNet
    • Baccarani, M., G. Saglio, J. Goldman, A. Hochhaus, B. Simonsson, F. Appelbaum, J. Apperley, F. Cervantes, J. Cortes, M. Deininger, et al; European LeukemiaNet. 2006. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 108:1809-1820. http://dx.doi.org/10.1182/blood-2006-02-005686
    • (2006) Blood , vol.108 , pp. 1809-1820
    • Baccarani, M.1    Saglio, G.2    Goldman, J.3    Hochhaus, A.4    Simonsson, B.5    Appelbaum, F.6    Apperley, J.7    Cervantes, F.8    Cortes, J.9    Deininger, M.10
  • 2
    • 77953462161 scopus 로고    scopus 로고
    • Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection
    • Baldridge, M.T., K.Y. King, N.C. Boles, D.C. Weksberg, and M.A. Goodell. 2010. Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection. Nature. 465:793-797. http://dx.doi.org/10.1038/nature09135
    • (2010) Nature. , vol.465 , pp. 793-797
    • Baldridge, M.T.1    King, K.Y.2    Boles, N.C.3    Weksberg, D.C.4    Goodell, M.A.5
  • 3
    • 66449122303 scopus 로고    scopus 로고
    • Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells
    • Bellodi, C., M.R. Lidonnici, A. Hamilton, G.V. Helgason, A.R. Soliera, M. Ronchetti, S. Galavotti, K.W. Young, T. Selmi, R. Yacobi, et al. 2009. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 119:1109-1123. http://dx.doi.org/10.1172/JCI35660
    • (2009) J. Clin. Invest. , vol.119 , pp. 1109-1123
    • Bellodi, C.1    Lidonnici, M.R.2    Hamilton, A.3    Helgason, G.V.4    Soliera, A.R.5    Ronchetti, M.6    Galavotti, S.7    Young, K.W.8    Selmi, T.9    Yacobi, R.10
  • 4
    • 77952581999 scopus 로고    scopus 로고
    • Induction of an IL7-R(+)c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-gamma signaling during acute malaria
    • Belyaev, N.N., D.E. Brown, A.I. Diaz, A. Rae, W. Jarra, J. Thompson, J. Langhorne, and A.J. Potocnik. 2010. Induction of an IL7-R(+)c-Kit(hi) myelolymphoid progenitor critically dependent on IFN-gamma signaling during acute malaria. Nat. Immunol. 11:477-485. http://dx.doi.org/10.1038/ni.1869
    • (2010) Nat. Immunol. , vol.11 , pp. 477-485
    • Belyaev, N.N.1    Brown, D.E.2    Diaz, A.I.3    Rae, A.4    Jarra, W.5    Thompson, J.6    Langhorne, J.7    Potocnik, A.J.8
  • 5
    • 0030848161 scopus 로고    scopus 로고
    • Induction of a CD8+ cytotoxic T lymphocyte response by crosspriming requires cognate CD4+ T cell help
    • Bennett, S.R., F.R. Carbone, F. Karamalis, J.F. Miller, and W.R. Heath. 1997. Induction of a CD8+ cytotoxic T lymphocyte response by crosspriming requires cognate CD4+ T cell help. J. Exp. Med. 186:65-70. http://dx.doi.org/10.1084/jem.186.1.65
    • (1997) J. Exp. Med. , vol.186 , pp. 65-70
    • Bennett, S.R.1    Carbone, F.R.2    Karamalis, F.3    Miller, J.F.4    Heath, W.R.5
  • 6
    • 73349143984 scopus 로고    scopus 로고
    • Niche recycling through division-independent egress of hematopoietic stem cells
    • Bhattacharya, D., A. Czechowicz, A.G. Ooi, D.J. Rossi, D. Bryder, and I.L. Weissman. 2009. Niche recycling through division-independent egress of hematopoietic stem cells. J. Exp. Med. 206:2837-2850. http://dx.doi.org/10.1084/jem.20090778
    • (2009) J. Exp. Med. , vol.206 , pp. 2837-2850
    • Bhattacharya, D.1    Czechowicz, A.2    Ooi, A.G.3    Rossi, D.J.4    Bryder, D.5    Weissman, I.L.6
  • 8
    • 0032102284 scopus 로고    scopus 로고
    • Lack of strong immune selection pressure bythe immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection
    • Brander, C., K.E. Hartman, A.K. Trocha, N.G. Jones, R.P. Johnson, B. Korber, P. Wentworth, S.P. Buchbinder, S. Wolinsky, B.D. Walker, and S.A. Kalams. 1998. Lack of strong immune selection pressure bythe immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J. Clin. Invest. 101:2559-2566. http://dx.doi.org/10.1172/JCI2405
    • (1998) J. Clin. Invest. , vol.101 , pp. 2559-2566
    • Brander, C.1    Hartman, K.E.2    Trocha, A.K.3    Jones, N.G.4    Johnson, R.P.5    Korber, B.6    Wentworth, P.7    Buchbinder, S.P.8    Wolinsky, S.9    Walker, B.D.10    Kalams, S.A.11
  • 9
    • 27144470690 scopus 로고    scopus 로고
    • Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects
    • Butt, N.M., J.M. Rojas, L. Wang, S.E. Christmas, H.M. Abu-Eisha, and R.E. Clark. 2005. Circulating bcr-abl-specific CD8+ T cells in chronic myeloid leukemia patients and healthy subjects. Haematologica. 90:1315-1323.
    • (2005) Haematologica. , vol.90 , pp. 1315-1323
    • Butt, N.M.1    Rojas, J.M.2    Wang, L.3    Christmas, S.E.4    Abu-Eisha, H.M.5    Clark, R.E.6
  • 11
    • 0035092803 scopus 로고    scopus 로고
    • The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse
    • Carlens, S., M. Remberger, J. Aschan, and O. Ringdén. 2001. The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse. Biol. Blood Marrow Transplant. 7:31-38. http://dx.doi.org/10.1053/bbmt.2001.v7.pm11215696
    • (2001) Biol. Blood Marrow Transplant. , vol.7 , pp. 31-38
    • Carlens, S.1    Remberger, M.2    Aschan, J.3    Ringdén, O.4
  • 12
    • 0035892131 scopus 로고    scopus 로고
    • Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein
    • Clark, R.E., I.A. Dodi, S.C. Hill, J.R. Lill, G. Aubert, A.R. Macintyre, J. Rojas, A. Bourdon, P.L. Bonner, L. Wang, et al. 2001. Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood. 98:2887-2893. http://dx.doi.org/10.1182/blood.V98.10.2887
    • (2001) Blood. , vol.98 , pp. 2887-2893
    • Clark, R.E.1    Dodi, I.A.2    Hill, S.C.3    Lill, J.R.4    Aubert, G.5    Macintyre, A.R.6    Rojas, J.7    Bourdon, A.8    Bonner, P.L.9    Wang, L.10
  • 14
    • 7244223336 scopus 로고    scopus 로고
    • Characterization of acute lymphoblastic leukemia progenitor cells
    • Cox, C.V., R.S. Evely, A. Oakhill, D.H. Pamphilon, N.J. Goulden, and A. Blair. 2004. Characterization of acute lymphoblastic leukemia progenitor cells. Blood. 104:2919-2925. http://dx.doi.org/10.1182/blood-2004-03-0901
    • (2004) Blood. , vol.104 , pp. 2919-2925
    • Cox, C.V.1    Evely, R.S.2    Oakhill, A.3    Pamphilon, D.H.4    Goulden, N.J.5    Blair, A.6
  • 15
    • 0027400726 scopus 로고
    • Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
    • Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1739-1742. http://dx.doi.org/10.1126/science.8456300
    • (1993) Science. , vol.259 , pp. 1739-1742
    • Dalton, D.K.1    Pitts-Meek, S.2    Keshav, S.3    Figari, I.S.4    Bradley, A.5    Stewart, T.A.6
  • 16
    • 0034660923 scopus 로고    scopus 로고
    • No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia
    • Deininger, M., T. Lehmann, R. Krahl, E. Hennig, C. Müller, and D. Niederwieser. 2000. No evidence for persistence of BCR-ABL-positive cells in patients in molecular remission after conventional allogenic transplantation for chronic myeloid leukemia. Blood. 96:779-780.
    • (2000) Blood. , vol.96 , pp. 779-780
    • Deininger, M.1    Lehmann, T.2    Krahl, R.3    Hennig, E.4    Müller, C.5    Niederwieser, D.6
  • 17
    • 0035810142 scopus 로고    scopus 로고
    • Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
    • Druker, B.J., C.L. Sawyers, H. Kantarjian, D.J. Resta, S.F. Reese, J.M. Ford, R. Capdeville, and M. Talpaz. 2001a. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344:1038-1042. http://dx.doi.org/10.1056/NEJM200104053441402
    • (2001) N. Engl. J. Med. , vol.344 , pp. 1038-1042
    • Druker, B.J.1    Sawyers, C.L.2    Kantarjian, H.3    Resta, D.J.4    Reese, S.F.5    Ford, J.M.6    Capdeville, R.7    Talpaz, M.8
  • 20
    • 0032473581 scopus 로고    scopus 로고
    • Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology
    • Ehl, S., J. Hombach, P. Aichele, T. Rülicke, B. Odermatt, H. Hengartner, R. Zinkernagel, and H. Pircher. 1998. Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J. Exp. Med. 187:763-774. http://dx.doi.org/10.1084/jem.187.5.763
    • (1998) J. Exp. Med. , vol.187 , pp. 763-774
    • Ehl, S.1    Hombach, J.2    Aichele, P.3    Rülicke, T.4    Odermatt, B.5    Hengartner, H.6    Zinkernagel, R.7    Pircher, H.8
  • 23
    • 0027411525 scopus 로고
    • The molecular cell biology of interferon- gamma and its receptor
    • Farrar, M.A., and R.D. Schreiber. 1993. The molecular cell biology of interferon- gamma and its receptor. Annu. Rev. Immunol. 11:571-611. http://dx.doi.org/10.1146/annurev.iy.11.040193.003035
    • (1993) Annu. Rev. Immunol. , vol.11 , pp. 571-611
    • Farrar, M.A.1    Schreiber, R.D.2
  • 25
    • 39649085170 scopus 로고    scopus 로고
    • Rapid and selective deathof leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8)
    • Guzman, M.L., X. Li, C.A. Corbett, R.M. Rossi, T. Bushnell, J.L. Liesveld, J. Hébert, F. Young, and C.T. Jordan. 2007. Rapid and selective deathof leukemia stem and progenitor cells induced by the compound 4-benzyl, 2-methyl, 1,2,4-thiadiazolidine, 3,5 dione (TDZD-8). Blood. 110:4436- 4444. http://dx.doi.org/10.1182/blood-2007-05-088815
    • (2007) Blood. , vol.110
    • Guzman, M.L.1    Li, X.2    Corbett, C.A.3    Rossi, R.M.4    Bushnell, T.5    Liesveld, J.L.6    Hébert, J.7    Young, F.8    Jordan, C.T.9
  • 27
    • 10744229080 scopus 로고    scopus 로고
    • Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia
    • International Randomised Study of Interferon versus STI571 (IRIS) Study Group
    • Hughes, T.P., J. Kaeda, S. Branford, Z. Rudzki, A. Hochhaus, M.L. Hensley, I. Gathmann, A.E. Bolton, I.C. van Hoomissen, J.M. Goldman, and J.P. Radich; International Randomised Study of Interferon versus STI571 (IRIS) Study Group. 2003. Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia. N. Engl. J. Med. 349:1423-1432. http://dx.doi.org/10.1056/NEJMoa030513
    • (2003) N. Engl. J. Med. , vol.349 , pp. 1423-1432
    • Hughes, T.P.1    Kaeda, J.2    Branford, S.3    Rudzki, Z.4    Hochhaus, A.5    Hensley, M.L.6    Gathmann, I.7    Bolton, A.E.8    Van Hoomissen, I.C.9    Goldman, J.M.10    Radich, J.P.11
  • 29
    • 33749515476 scopus 로고    scopus 로고
    • Targeting of CD44 eradicates human acute myeloid leukemic stem cells
    • Jin, L., K.J. Hope, Q. Zhai, F. Smadja-Joffe, and J.E. Dick. 2006. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat. Med. 12:1167-1174. http://dx.doi.org/10.1038/nm1483
    • (2006) Nat. Med. , vol.12 , pp. 1167-1174
    • Jin, L.1    Hope, K.J.2    Zhai, Q.3    Smadja-Joffe, F.4    Dick, J.E.5
  • 30
    • 45549088480 scopus 로고    scopus 로고
    • Chronic myeloid leukemia stem cells
    • Kavalerchik, E., D. Goff, and C.H. Jamieson. 2008. Chronic myeloid leukemia stem cells. J. Clin. Oncol. 26:2911-2915. http://dx.doi.org/10.1200/JCO.2008.17.5745
    • (2008) J. Clin. Oncol. , vol.26 , pp. 2911-2915
    • Kavalerchik, E.1    Goff, D.2    Jamieson, C.H.3
  • 31
    • 41149109622 scopus 로고    scopus 로고
    • Uncertainty in the niches that maintain haematopoietic stem cells
    • Kiel, M.J., and S.J. Morrison. 2008. Uncertainty in the niches that maintain haematopoietic stem cells. Nat. Rev. Immunol. 8:290-301. http://dx.doi.org/10.1038/nri2279
    • (2008) Nat. Rev. Immunol. , vol.8 , pp. 290-301
    • Kiel, M.J.1    Morrison, S.J.2
  • 32
    • 0025678601 scopus 로고
    • Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
    • Kolb, H.J., J. Mittermüller, C. Clemm, E. Holler, G. Ledderose, G. Brehm, M. Heim, and W. Wilmanns. 1990. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood. 76:2462-2465.
    • (1990) Blood. , vol.76 , pp. 2462-2465
    • Kolb, H.J.1    Mittermüller, J.2    Clemm, C.3    Holler, E.4    Ledderose, G.5    Brehm, G.6    Heim, M.7    Wilmanns, W.8
  • 33
    • 0029100438 scopus 로고
    • Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
    • European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia
    • Kolb, H.J., A. Schattenberg, J.M. Goldman, B. Hertenstein, N. Jacobsen, W. Arcese, P. Ljungman, A. Ferrant, L. Verdonck, D. Niederwieser, et al; European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. 1995. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood. 86:2041-2050.
    • (1995) Blood. , vol.86 , pp. 2041-2050
    • Kolb, H.J.1    Schattenberg, A.2    Goldman, J.M.3    Hertenstein, B.4    Jacobsen, N.5    Arcese, W.6    Ljungman, P.7    Ferrant, A.8    Verdonck, L.9    Niederwieser, D.10
  • 34
    • 33749521890 scopus 로고    scopus 로고
    • Requirement for CD44 in homing and engraftment of BCR-ABLexpressing leukemic stem cells
    • Krause, D.S., K. Lazarides, U.H. von Andrian, and R.A. Van Etten. 2006. Requirement for CD44 in homing and engraftment of BCR-ABLexpressing leukemic stem cells. Nat. Med. 12:1175-1180. http://dx.doi.org/10.1038/nm1489
    • (2006) Nat. Med. , vol.12 , pp. 1175-1180
    • Krause, D.S.1    Lazarides, K.2    Von Andrian, U.H.3    Van Etten, R.A.4
  • 35
    • 77952553096 scopus 로고    scopus 로고
    • Interferon-gamma-mediated pathways are induced in human CD34(+) haematopoietic stem cells
    • Kurz, K., Y. Gluhcheva, E. Zvetkova, G. Konwalinka, and D. Fuchs. 2010. Interferon-gamma-mediated pathways are induced in human CD34(+) haematopoietic stem cells. Immunobiology. 215:452-457. http://dx.doi.org/10.1016/j.imbio.2009.08.007
    • (2010) Immunobiology. , vol.215 , pp. 452-457
    • Kurz, K.1    Gluhcheva, Y.2    Zvetkova, E.3    Konwalinka, G.4    Fuchs, D.5
  • 37
    • 84863011183 scopus 로고    scopus 로고
    • Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib
    • Li, L., L. Wang, L. Li, Z. Wang, Y. Ho, T. McDonald, T.L. Holyoake, W. Chen, and R. Bhatia. 2012. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell. 21:266-281. http://dx.doi.org/10.1016/j.ccr.2011.12.020
    • (2012) Cancer Cell. , vol.21 , pp. 266-281
    • Li, L.1    Wang, L.2    Li, L.3    Wang, Z.4    Ho, Y.5    Mcdonald, T.6    Holyoake, T.L.7    Chen, W.8    Bhatia, R.9
  • 38
    • 0034610974 scopus 로고    scopus 로고
    • Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease
    • Ludewig, B., A.F. Ochsenbein, B. Odermatt, D. Paulin, H. Hengartner, and R.M. Zinkernagel. 2000. Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J. Exp. Med. 191:795-804. http://dx.doi.org/10.1084/jem.191.5.795
    • (2000) J. Exp. Med. , vol.191 , pp. 795-804
    • Ludewig, B.1    Ochsenbein, A.F.2    Odermatt, B.3    Paulin, D.4    Hengartner, H.5    Zinkernagel, R.M.6
  • 39
    • 79251562853 scopus 로고    scopus 로고
    • Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-γ signaling
    • MacNamara, K.C., K. Oduro, O. Martin, D.D. Jones, M. McLaughlin, K. Choi, D.L. Borjesson, and G.M. Winslow. 2011. Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-γ signaling. J. Immunol. 186:1032-1043. http://dx.doi.org/10.4049/jimmunol.1001893
    • (2011) J. Immunol. , vol.186 , pp. 1032-1043
    • Macnamara, K.C.1    Oduro, K.2    Martin, O.3    Jones, D.D.4    Mclaughlin, M.5    Choi, K.6    Borjesson, D.L.7    Winslow, G.M.8
  • 40
    • 67650632683 scopus 로고    scopus 로고
    • CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells
    • Majeti, R., M.P. Chao, A.A. Alizadeh, W.W. Pang, S. Jaiswal, K.D. Gibbs Jr., N. van Rooijen, and I.L. Weissman. 2009. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell. 138:286-299. http://dx.doi.org/10.1016/j.cell.2009.05.045
    • (2009) Cell. , vol.138 , pp. 286-299
    • Majeti, R.1    Chao, M.P.2    Alizadeh, A.A.3    Pang, W.W.4    Jaiswal, S.5    Gibbs Jr., K.D.6    Van Rooijen, N.7    Weissman, I.L.8
  • 42
    • 33748462545 scopus 로고    scopus 로고
    • Elimination of chronic viral infection by blocking CD27 signaling
    • Matter, M., B. Odermatt, H. Yagita, J.M. Nuoffer, and A.F. Ochsenbein. 2006. Elimination of chronic viral infection by blocking CD27 signaling. J. Exp. Med. 203:2145-2155. http://dx.doi.org/10.1084/jem.20060651
    • (2006) J. Exp. Med. , vol.203 , pp. 2145-2155
    • Matter, M.1    Odermatt, B.2    Yagita, H.3    Nuoffer, J.M.4    Ochsenbein, A.F.5
  • 43
    • 0028891726 scopus 로고
    • Pathogenesis of the anemia of chronic disease: a cytokine- mediated anemia
    • Means, R.T. Jr. 1995. Pathogenesis of the anemia of chronic disease: a cytokine- mediated anemia. Stem Cells. 13:32-37. http://dx.doi.org/10.1002/stem.5530130105
    • (1995) Stem Cells. , vol.13 , pp. 32-37
    • Means Jr., R.T.1
  • 44
    • 38349157811 scopus 로고    scopus 로고
    • Hematopoietic cytokines
    • Metcalf, D. 2008. Hematopoietic cytokines. Blood. 111:485-491. http://dx.doi.org/10.1182/blood-2007-03-079681
    • (2008) Blood. , vol.111 , pp. 485-491
    • Metcalf, D.1
  • 45
    • 0033826799 scopus 로고    scopus 로고
    • Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia
    • Molldrem, J.J., P.P. Lee, C. Wang, K. Felio, H.M. Kantarjian, R.E. Champlin, and M.M. Davis. 2000. Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia. Nat. Med. 6:1018-1023. http://dx.doi.org/10.1038/79526
    • (2000) Nat. Med. , vol.6 , pp. 1018-1023
    • Molldrem, J.J.1    Lee, P.P.2    Wang, C.3    Felio, K.4    Kantarjian, H.M.5    Champlin, R.E.6    Davis, M.M.7
  • 46
    • 33751167425 scopus 로고    scopus 로고
    • Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections
    • Mumprecht, S., M. Matter, V. Pavelic, and A.F. Ochsenbein. 2006. Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections. Blood. 108: 3406-3413. http://dx.doi.org/10.1182/blood-2006-04-018705
    • (2006) Blood. , vol.108 , pp. 3406-3413
    • Mumprecht, S.1    Matter, M.2    Pavelic, V.3    Ochsenbein, A.F.4
  • 47
    • 66549117391 scopus 로고    scopus 로고
    • Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells
    • Mumprecht, S., C. Claus, C. Schürch, V. Pavelic, M.S. Matter, and A.F. Ochsenbein. 2009a. Defective homing and impaired induction of cytotoxic T cells by BCR/ABL-expressing dendritic cells. Blood. 113:4681- 4689. http://dx.doi.org/10.1182/blood-2008-05-156471
    • (2009) Blood. , vol.113
    • Mumprecht, S.1    Claus, C.2    Schürch, C.3    Pavelic, V.4    Matter, M.S.5    Ochsenbein, A.F.6
  • 48
    • 70349562580 scopus 로고    scopus 로고
    • Programmed death 1 signaling on chronic myeloid leukemiaspecific T cells results in T-cell exhaustion and disease progression
    • Mumprecht, S., C. Schürch, J. Schwaller, M. Solenthaler, and A.F. Ochsenbein. 2009b. Programmed death 1 signaling on chronic myeloid leukemiaspecific T cells results in T-cell exhaustion and disease progression. Blood. 114:1528-1536. http://dx.doi.org/10.1182/blood-2008-09-179697
    • (2009) Blood. , vol.114 , pp. 1528-1536
    • Mumprecht, S.1    Schürch, C.2    Schwaller, J.3    Solenthaler, M.4    Ochsenbein, A.F.5
  • 49
    • 77957167070 scopus 로고    scopus 로고
    • Chronic myelogenous leukemia maintains specific CD8(+) T cells through IL-7 signaling
    • Mumprecht, S., C. Schürch, S. Scherrer, C. Claus, and A.F. Ochsenbein. 2010. Chronic myelogenous leukemia maintains specific CD8(+) T cells through IL-7 signaling. Eur. J. Immunol. 40:2720-2730. http://dx.doi.org/10.1002/eji.201040404
    • (2010) Eur. J. Immunol. , vol.40 , pp. 2720-2730
    • Mumprecht, S.1    Schürch, C.2    Scherrer, S.3    Claus, C.4    Ochsenbein, A.F.5
  • 51
    • 34648832173 scopus 로고    scopus 로고
    • FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
    • Neviani, P., R. Santhanam, J.J. Oaks, A.M. Eiring, M. Notari, B.W. Blaser, S. Liu, R. Trotta, N. Muthusamy, C. Gambacorti-Passerini, et al. 2007. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J. Clin. Invest. 117:2408-2421. http://dx.doi.org/10.1172/JCI31095
    • (2007) J. Clin. Invest. , vol.117 , pp. 2408-2421
    • Neviani, P.1    Santhanam, R.2    Oaks, J.J.3    Eiring, A.M.4    Notari, M.5    Blaser, B.W.6    Liu, S.7    Trotta, R.8    Muthusamy, N.9    Gambacorti-Passerini, C.10
  • 52
    • 0030971268 scopus 로고    scopus 로고
    • HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice
    • Pascolo, S., N. Bervas, J.M. Ure, A.G. Smith, F.A. Lemonnier, and B. Pérarnau. 1997. HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J. Exp. Med. 185:2043-2051. http://dx.doi.org/10.1084/jem.185.12.2043
    • (1997) J. Exp. Med. , vol.185 , pp. 2043-2051
    • Pascolo, S.1    Bervas, N.2    Ure, J.M.3    Smith, A.G.4    Lemonnier, F.A.5    Pérarnau, B.6
  • 53
    • 0024307348 scopus 로고
    • Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen
    • Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M. Zinkernagel. 1989. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 342:559-561. http://dx.doi.org/10.1038/342559a0
    • (1989) Nature. , vol.342 , pp. 559-561
    • Pircher, H.1    Bürki, K.2    Lang, R.3    Hengartner, H.4    Zinkernagel, R.M.5
  • 54
    • 80051720194 scopus 로고    scopus 로고
    • Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia
    • Porter, D.L., B.L. Levine, M. Kalos, A. Bagg, and C.H. June. 2011. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365:725-733. http://dx.doi.org/10.1056/NEJMoa1103849
    • (2011) N. Engl. J. Med. , vol.365 , pp. 725-733
    • Porter, D.L.1    Levine, B.L.2    Kalos, M.3    Bagg, A.4    June, C.H.5
  • 56
    • 42549142280 scopus 로고    scopus 로고
    • Getting to the stem of chronic myeloid leukaemia
    • Savona, M., and M. Talpaz. 2008. Getting to the stem of chronic myeloid leukaemia. Nat. Rev. Cancer. 8:341-350. http://dx.doi.org/10.1038/nrc2368 Sawyers, C.L. 1999. Chronic myeloid leukemia. N. Engl. J. Med. 340:1330-1340. http://dx.doi.org/10.1056/NEJM199904293401706
    • (2008) Nat. Rev. Cancer. , vol.8 , pp. 341-350
    • Savona, M.1    Talpaz, M.2
  • 57
    • 0033614446 scopus 로고    scopus 로고
    • Chronic myeloid leukemia
    • Sawyers, C.L. 1999. Chronic myeloid leukemia. N. Engl. J. Med. 340:1330-1340. http://dx.doi.org/10.1056/NEJM199904293401706
    • (1999) N. Engl. J. Med. , vol.340 , pp. 1330-1340
    • Sawyers, C.L.1
  • 58
    • 79953151458 scopus 로고    scopus 로고
    • Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion
    • Schreiber, R.D., L.J. Old, and M.J. Smyth. 2011. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 331:1565-1570. http://dx.doi.org/10.1126/science.1203486
    • (2011) Science. , vol.331 , pp. 1565-1570
    • Schreiber, R.D.1    Old, L.J.2    Smyth, M.J.3
  • 59
    • 84856512553 scopus 로고    scopus 로고
    • CD27 signaling on chronic myelogenous leukemia stem cellsactivates Wnt target genes and promotes disease progression
    • Schürch, C., C. Riether, M.S. Matter, A. Tzankov, and A.F. Ochsenbein. 2012. CD27 signaling on chronic myelogenous leukemia stem cellsactivates Wnt target genes and promotes disease progression. J. Clin. Invest. 122:624-638. http://dx.doi.org/10.1172/JCI45977
    • (2012) J. Clin. Invest. , vol.122 , pp. 624-638
    • Schürch, C.1    Riether, C.2    Matter, M.S.3    Tzankov, A.4    Ochsenbein, A.F.5
  • 60
    • 0033015210 scopus 로고    scopus 로고
    • Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion
    • Sehn, L.H., E.P. Alyea, E. Weller, C. Canning, S. Lee, J. Ritz, J.H. Antin, and R.J. Soiffer. 1999. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion. J. Clin. Oncol. 17:561-568.
    • (1999) J. Clin. Oncol. , vol.17 , pp. 561-568
    • Sehn, L.H.1    Alyea, E.P.2    Weller, E.3    Canning, C.4    Lee, S.5    Ritz, J.6    Antin, J.H.7    Soiffer, R.J.8
  • 61
    • 0034071255 scopus 로고    scopus 로고
    • The role of FAS-mediated apoptosis in chronic myelogenous leukemia
    • Selleri, C., and J.P. Maciejewski. 2000. The role of FAS-mediated apoptosis in chronic myelogenous leukemia. Leuk. Lymphoma. 37:283-297.
    • (2000) Leuk. Lymphoma. , vol.37 , pp. 283-297
    • Selleri, C.1    Maciejewski, J.P.2
  • 64
    • 0029099230 scopus 로고
    • Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine
    • Wang, R., Y. Charoenvit, G. Corradin, R. Porrozzi, R.L. Hunter, G. Glenn, C.R. Alving, P. Church, and S.L. Hoffman. 1995. Induction of protective polyclonal antibodies by immunization with Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J. Immunol. 155:1637.
    • (1995) J. Immunol. , vol.155 , pp. 1637
    • Wang, R.1    Charoenvit, Y.2    Corradin, G.3    Porrozzi, R.4    Hunter, R.L.5    Glenn, G.6    Alving, C.R.7    Church, P.8    Hoffman, S.L.9
  • 65
    • 77950287628 scopus 로고    scopus 로고
    • The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML
    • Wang, Y., A.V. Krivtsov, A.U. Sinha, T.E. North, W. Goessling, Z. Feng, L.I. Zon, and S.A. Armstrong. 2010. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science. 327:1650-1653. http://dx.doi.org/10.1126/science.1186624
    • (2010) Science. , vol.327 , pp. 1650-1653
    • Wang, Y.1    Krivtsov, A.V.2    Sinha, A.U.3    North, T.E.4    Goessling, W.5    Feng, Z.6    Zon, L.I.7    Armstrong, S.A.8
  • 66
    • 0018764352 scopus 로고
    • Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts
    • Weiden, P.L., N. Flournoy, E.D. Thomas, R. Prentice, A. Fefer, C.D. Buckner, and R. Storb. 1979. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts. N. Engl. J. Med. 300:1068-1073. http://dx.doi.org/10.1056/NEJM197905103001902
    • (1979) N. Engl. J. Med. , vol.300 , pp. 1068-1073
    • Weiden, P.L.1    Flournoy, N.2    Thomas, E.D.3    Prentice, R.4    Fefer, A.5    Buckner, C.D.6    Storb, R.7
  • 67
    • 14744278436 scopus 로고    scopus 로고
    • Anemia of chronic disease
    • Weiss, G., and L.T. Goodnough. 2005. Anemia of chronic disease. N. Engl. J. Med. 352:1011-1023. http://dx.doi.org/10.1056/NEJMra041809
    • (2005) N. Engl. J. Med. , vol.352 , pp. 1011-1023
    • Weiss, G.1    Goodnough, L.T.2
  • 71
    • 35548931073 scopus 로고    scopus 로고
    • Pathophysiologic mechanisms in acquired aplastic anemia
    • Young, N.S. 2006. Pathophysiologic mechanisms in acquired aplastic anemia. Hematology (Am Soc Hematol Educ Program). 1:72-77. http://dx.doi.org/10.1182/asheducation-2006.1.72
    • (2006) Hematology (Am Soc Hematol Educ Program). , vol.1 , pp. 72-77
    • Young, N.S.1
  • 72
  • 73
    • 44349150012 scopus 로고    scopus 로고
    • Inhibitory B7-family molecules in the tumour microenvironment
    • Zou, W., and L. Chen. 2008. Inhibitory B7-family molecules in the tumour microenvironment. Nat. Rev. Immunol. 8:467-477. http://dx.doi.org/10.1038/nri2326
    • (2008) Nat. Rev. Immunol. , vol.8 , pp. 467-477
    • Zou, W.1    Chen, L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.